Composition
- Active ingredients
- CHLORTHALIDONE 25MG; RESERPINE 0.125MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA015103.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Demi-Regroton
- Active substance
- chlorthalidone
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Sanofi Aventis US
- Status
- Discontinued
- FDA approval
- 8 May 1964
- Application
- NDA015103-002